Yaroslavl Oblast Government. The Yaroslavl Oblast pharmaceutical industry and medical innovation cluster

Size: px
Start display at page:

Download "Yaroslavl Oblast Government. The Yaroslavl Oblast pharmaceutical industry and medical innovation cluster"

Transcription

1 The Yaroslavl Oblast pharmaceutical industry and medical innovation cluster

2 Ярославский кластер современной фармацевтической Cluster premises промышленности for success и инновационной медицины 100 years experience in chemistry industry, with four generations of professionals 20 years of international R&D experience Partnership with medical schools in Russia and abroad Available and highly skilled workforce Location in the center of the largest domestic market Localization of leading pharmaceutical companies plants Development of pharmaceutical production a top priority in investment strategy of the Oblast Facilities of industrial sites Communal infrastructure resources Reasonable energy prices 2

3 Key stages of formation and development of the cluster September 2012 Completion of Takeda plant construction April 2010 start of R-Pharm plant construction December 2011 start of construction of the Technology Transfer Center September 2011 TEVA signed an agreement on plant construction August 2011 Completion of the first stage of R-Pharm plant construction. Start of the second stage. The decision to establish the Technology Transfer Center was fixed in FTP November Zvorynskaya Prize was awarded to Intelligent dialogue" Signed an agreement with GlaxoSmithKlein Winning the competition for vocational education Signed an agreement with Novartis, clinical research An agreement with Ranbaxy for scientific and educational research Novartis running the cardiology project October2009 cluster was included into the Federal Pharma 2020 program July2009 Cluster formation was supported by Vladimir Putin August2009 Formation of the Oblast Cluster Council under coordination of the Department for Economic Development of Yaroslavl Oblast June 2009 Concept of cluster politics was approved by the of Yaroslavl Oblast December concept for cluster development was supported by federal Agency of Strategic Initiatives and Business Russia 2012 January 2012 coordinator Agency for Investment and Cluster Development of Yaroslavl Oblast, was established by the of Yaroslavl Oblast

4 Place of the Yaroslavl Oblast pharmaceutical cluster on the domestic market Growth of sales and production of the cluster(%) in bln.rur , ,0 Little or nothing 110, Production cluster in Russian The Russian market (projected by Minpromtorg of Russian) Share of the cluster on the domestic pharmaceutical market over 13% Pharmaceutical cluster sales localization 4

5 Industrial projects of the cluster Total amount of investment 25,7 billion rubles at the first stage Projects Amount of investment The end of construction Teva 1) Plant for producing of various over-the-counter health products, Yaroslavl 2) R&D center 10,5 billion rubles 1) 2014 year 2) 2018 year Nycomed R-Pharm Plant for producing of various over-the-counter medicine, Yaroslavl 1) Plant to produce various over-the-counter medicine in the way of pills/tablets/capsules, Yaroslavl 2) Pharmoslavl chemical plant for production of active pharmaceutical ingredients of chemical origin 3) Plant for manufacturing of biotechnological substances 4) Logistical complex 2,4 billion rubles 2012 year 10,6 billion rubles 1) completed 2) 2013 year 3) 2013 year 4) 2013 year Plant for microbicides manufacturing 0,64 billion rubles 2013 year VitaFarma ROSNANO (NT-Pharma) Plant for vaccines manufacturing, Rostov, Yaroslavl Oblast 1,6 billion rubles 2014 year 5

6 Structure of the pharmaceutical cluster of Yaroslavl Oblast Legal and financial consultants Companies for production packaging Supply companies Industrial sites Transportation and logistics companies Investors Specialized service companies Programs for additional education in cooperation with international pharmaceutical company Ranbaxy Center for educational programs and academic mobility on the basis of YAGMA university in Yaroslavl Specialized educational institutions of Yaroslavl Oblast Regional Health System Personnel Production, storage, transportation, sale, disposal CORE OF THE CLUSTER TEVA R-Pharm Takeda (Nycomed) Rosnano (NT-Pharma) Farmoslavl VITAFARMA Local coordinator - Agency for Investment and Cluster Development of Yaroslavl Oblast Scientific research Center for clinical research, pharmacokinetic and bioequivalence of medicines in Yaroslavl The Technology Transfer Center on the basis of YAGP university "Intellectual Dialogue" - a center of making infection control drug agents In Yaroslavl Modernization of cardiology services in the Oblast Development of health system in the Oblast jointly with Ranbaxy Agreements and the legal base Concept for development of pharmaceutical cluster in Yaroslavl Oblast Federal and Oblast Ministry of Industry of Russian Federation: Pharma Development Strategy 2020 Ministry of Industry of Russia: FPP "Development of the pharmaceutical industry through 2020"

7 Location of the cluster companies in the Oblast LLC Farmoslavl plant for the production of active substances LLC NT-Pharma plant for production of nanovaccines CJSC Company Vitafarma Pereslavl Yaroslavl Rostov LLC Teva plant for production of various medical products in the form of pills/tablets/capsules CJSC R-Pharm plant to produce various prescription and overthe-counter medicine in the form of pills, tablets or capsules LLC Industrial company plant for over-the-counter health products production Yaroslavl State Medical Academy Yaroslavl State Pedagogical University Yaroslavl State Technical University Yaroslavl State University Chemistry and Technology College Scientific and Educational Center Innovative Research LLC "Intellectual Dialogue" LLC Technology Transfer Center on the basis of YAGPU university LLC Novartis Pharma The international company, "Ranbaxy Laboratories Limited Agency for Investment and Cluster Development of Yaroslavl Oblast JSC "Yaroslavl Industrial Site" Department for Economic Development of Yaroslavl Oblast Department for Public Health and Pharmacy of Yaroslavl Oblast

8 Some general issues foreign companies may face when starting business in Russia (with proposed solutions) Issues? We develop Solutions! Shortage or high cost of vacant sites for starting new business Program for investment sites development Shortage of skilled personnel Projects for personnel training in cooperation with cluster companies Administrative barriers Formation of Steering Council and Agency for Investment and Cluster Development Obsolete equipment The implementation of projects under the Federal Program Development of Medical and Pharmaceutical Industry of the Russian Federation for

9 Organizational framework Governor of Yaroslavl Oblast Steering Council Coordinator of the cluster (Agency for Investment and Cluster Development) Management Company (NPO Pharmaceutical Cluster of Yaroslavl Oblast)

10 Major projects Infrastructural projects in transport, energy, engineering, housing infrastructure Construction of water supply and treatment station in industrial sites Novoselki, Krasnoe, Construction of a thermal power plant Huadyan- Teninskaya CCGT -TPP, power MW, Construction of CCGT Rostov (26 MVA), CCGT Pereslavl (52MVA), CCGT Novoselki (52 MVA), CCGT for Farmaslavl company Reconstruction of Tunoshna airport (Yaroslavl) Pharmaceutical industry Teva, R-Pharm, Takeda, Farmoslavl, NTpharma Educational infrastructure Institute for Innovation Medicine and Pharmacy (jointly with YAGMA (Medical Academy) Center of post-graduate training for the pharmaceutical industry and innovative medicine (jointly with YAGTU (Yaroslavl State Technical University) Professional training for specialists in pharmaceutical sector : local universities and institutes Innovation Infrastructure Transfer Center for Regional Technology, development of medical products, clinical research jointly with YAGPU (Pharma Development Strategy 2020) Center for Diagnosis of Micro-and Nanostructures jointly with YarGU and FTIAN (Yaroslavl branch)

11 Scientific research and educational projects YAGMA YarGU YAGPU YAGTU Center for educational programs and academic mobility in association with Olympus Corporation and Medical University, Kazanava (Japan); Center for Clinical Pharmacology Center for additional professional education Professional training courses for the Oblast pharmaceutical cluster Yaroslavl Chemistry and Technology College: laboratory for chemical analysis equipment for instrumentation and automation control compressors and pumps technological driver electrician-setter Prospective sectors (greatest demand for skilled personnel): pharmaceutical engineering water and air treatment; logistics (pharmaceutical and medical); analytical chemistry (quality control, drugs, technology medical products); industrial ecology; medical insurance.

12 Cooperation with leading international companies Research and education project for pharmaceutical safety Project to optimize cardiology service in Yaroslavl Oblast Pulmonology project

13 Improving scientific, research and educational institutions The project under the Federal Program Development of Medical and Pharmaceutical Industry of the Russian Federation for Foundation of research infrastructure for pharmaceutical industry in the Oblast, technology development of new highly effective, national innovative and import substituting drugs The development of training for pharmaceutical companies personnel with a particular focus on pharmaceutical high-tech Laboratory type business incubator with total area of 8600 sq. m. 13

14 Yaroslavl Oblast Offers a place to enjoy a happy life qualified and skilled personnel developed infrastructure special institution to take investors through administrative barriers (Agency for Investment and Cluster Development)

15 Conclusion 1 2 Pharmaceutical cluster in Yaroslavl Oblast is the first pharmaceutical cluster formed in Russia (2009) The cluster is formed and financed by private business 3 We suggest cooperation for better results 4 Major pharmaceutical companies choose Yaroslavl Oblast to locate their production facilities

16 Thank you! Contacts: Director of Department of Economic Development Alexander Shutov Tel: +7 (4852) , Department of Economic Development Tel: +7 (4852) Fax: +7 (4852) Agency for Investment and Cluster Development of Yaroslavl Oblast - chief consultant Roman M. Prozorovskiy Tel: +7 (4852) info@icdy.ru Fax: +7 (4852) Web-site:

The development of pharmaceutical industry

The development of pharmaceutical industry REVIEW ARTICLE Possibilities of Import Substitution in the Russian Pharmaceutical Market Olga S. Peskova, Tatyana B. Boriskina, Tatyana D. Ungurayte, Svetlana I. Matyushchenko, Olga V. Urova Department

More information

Biotech & Pharma. Industries with the most favourable conditions for growth in Lublin

Biotech & Pharma. Industries with the most favourable conditions for growth in Lublin Biotech & Pharma Industries with the most favourable conditions for growth in Lublin Biotech & Pharma Biotechnology and pharmacy is one of the sectors with the most favourable conditions for growth in

More information

GEROPHARM NEW PARTNERING OPPORTUNITIES IN SAINT-PETERSBURG PHARMACEUTICAL CLUSTER

GEROPHARM NEW PARTNERING OPPORTUNITIES IN SAINT-PETERSBURG PHARMACEUTICAL CLUSTER GEROPHARM NEW PARTNERING OPPORTUNITIES IN SAINT-PETERSBURG PHARMACEUTICAL CLUSTER USD, billions Russian pharmaceutical market one of the most rapid growing markets in the world 30 25 22 25.5 20 19 16.9

More information

National Academic Reference Standards (NARS) Pharmacy. January st Edition

National Academic Reference Standards (NARS) Pharmacy. January st Edition National Academic Reference Standards (NARS) Pharmacy January 2009 1 st Edition Table of Contents Introduction to Pharmacy Education 1 National Academic Reference Standards 3 Curriculum Structure 10 Glossary

More information

CJSC Rafarma is a multi-purpose pharmaceutical integrated plant for production of all types of pharmaceutical forms of medicinal products of

CJSC Rafarma is a multi-purpose pharmaceutical integrated plant for production of all types of pharmaceutical forms of medicinal products of Our SLOGAN Healthto everyone Our HISTORY CJSC Rafarma is a multi-purpose pharmaceutical integrated plant for production of all types of pharmaceutical forms of medicinal products of different pharmacological

More information

NANOTECHNOLOGY AS A FACTOR IN THE DEVELOPMENT OF REGIONAL CLUSTERS

NANOTECHNOLOGY AS A FACTOR IN THE DEVELOPMENT OF REGIONAL CLUSTERS Original Scientific Paper doi:10.5937/jaes12-7165 Paper number: 12(2014)4, 303, 285-290 NANOTECHNOLOGY AS A FACTOR IN THE DEVELOPMENT OF REGIONAL CLUSTERS Sergey Vasilevich Kupriyanov* Zhanna Nikolaevna

More information

Manufacturing of pharmaceutical products in Russia under full cycle conditions

Manufacturing of pharmaceutical products in Russia under full cycle conditions Manufacturing of pharmaceutical products in Russia under full cycle conditions www.nacimbio.ru +7 (495) 649 96 30 Deputy director general of strategic development АО National Immunobiological company Andreeva

More information

Grindeks years of growth

Grindeks years of growth Grindeks years of growth Mission, vision and values of Grindeks Focus of Grindeks Business fields Turnover and profit TOP products of Grindeks Manufacturing value final dosage forms with high added value

More information

Distribution on the pharmaceutical market in CIS countries Comparative analysis of Russia, Ukraine and Kazakhstan

Distribution on the pharmaceutical market in CIS countries Comparative analysis of Russia, Ukraine and Kazakhstan Distribution on the pharmaceutical market in CIS countries 2015 2 Language: English Date of publication: February 2015 Delivery: pdf Price from: 2000 Find out Which countries plan to limit the number of

More information

JSC «INTER RAO UES» December 10,

JSC «INTER RAO UES» December 10, Russian Technology Platform Road Map «Environmentally Clean Thermal Power Generation of High Efficiency» Director of the Technology Platform, Deputy CEO of the Fund «Energy beyond borders» Prof., Dr. Sc.

More information

Resource Pack pharmaceutical & Healthcare

Resource Pack pharmaceutical & Healthcare 2016 Healthcare companies research, develop, produce and supply medicines (or pharmaceuticals ). The pills you take for your headache, your cold or any number of illnesses all come from the work of this

More information

Building Biotech Technology Transfer Opportunities

Building Biotech Technology Transfer Opportunities HEALTHCARE Building Biotech Technology Transfer Opportunities Sponsor and developer strategies for success By Alison Sahoo Alison Sahoo Alison Sahoo is a pharmaceutical industry analyst with more than

More information

Development of contract manufacturing on the example PJSC «Pharmimex»

Development of contract manufacturing on the example PJSC «Pharmimex» Development of contract manufacturing on the example PJSC «Pharmimex» Inga Aleksandrovna NIZHARADZE, Vice-President of PJSC «Pharmimex» www.pharmimex.com +7 (495) 692-48-48 www.skopinpharm.com +7 (49156)

More information

ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA

ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA Ministry of Industry and Trade/ Department of pharmaceutical and medical industry development Moscow September 22, 2017 MEDICINES CIRCULATION SYSTEM IN THE RUSSIAN FEDERATION Ministry of Healthcare Medicines

More information

Biotechnology Report CROATIA

Biotechnology Report CROATIA Biotechnology Report CROATIA PREPARED BY AND IN 2009 Bulgaria Croatia Industry Report STATUS OF THE CROATIAN BIOTECHNOLOGY SECTOR (Financial data in ) 2 Total Biotech Companies 2 Biotech-Therapeutic 0

More information

The Future of Pharmaceutical Quality

The Future of Pharmaceutical Quality The Future of Pharmaceutical Quality First SQA/BIRS Center Meeting Purdue University Polytechnic Institute Louis W. Yu, Ph.D. Chief Quality Officer Unique Challenges of the Pharmaceutical Industry a. The

More information

COMPANY PRESENTATION. Health is a treasure we share World Medicine World Medicine

COMPANY PRESENTATION. Health is a treasure we share World Medicine World Medicine COMPANY PRESENTATION 2012 World Medicine COMPANY OVERVIEW World Medicine is a global, innovation-driven, integrated pharmaceutical company. A rapidly growing pharmaceutical company in supplying high quality

More information

BioWorld s PARTNER in FOCUS: Open Innovations: Moscow

BioWorld s PARTNER in FOCUS: Open Innovations: Moscow BioWorld s PARTNER in FOCUS: Open Innovations: Moscow GLOBAL BIOPHARMA INDUSTRY SEES OPPORTUNITY IN RUSSIA Top executives from companies as diverse at Medtronic, Pfizer, EADS, Google, Sanofi Pasteur and

More information

Pharmaceutical Industries

Pharmaceutical Industries Taiwan Biotech and the Pharmaceutical Industries Chei-Hsiang Chen, Ph.D. Director, Biotechnology and Pharmaceutical Industries Program Office, Ministry of Economic Affairs, Taiwan The government has a

More information

Global Pharma Summit

Global Pharma Summit allied academies Global Pharma Summit September 03-04, September 03-04 Theme: Advanced Pharma Technologies-Better Healthcare system Sponsorship For More Details For Queries pharmaceutical@alliedmeetings.com

More information

Distribution on the pharmaceutical market in Russia Development forecasts for

Distribution on the pharmaceutical market in Russia Development forecasts for Distribution on the pharmaceutical market in Russia 2014 2 Language: English Date of publication: Q4 Delivery: pdf Price from: 950 Find out What is the saturation level of wholesale distribution in Russia?

More information

Medicine of the future: foresight

Medicine of the future: foresight State Government Financed Institution of Higher Professional Education Siberian State MedicalUniversity Ministry of Health and Social Development of the Russian Federation Medicine of the future: foresight

More information

Drivers for Continuous Tablet Manufacturing in Pharmaceutical Industry

Drivers for Continuous Tablet Manufacturing in Pharmaceutical Industry Drivers for Continuous Tablet Manufacturing in Pharmaceutical Industry Satu Lakio PhD (pharm.), Adj. Prof. Industrialisation and product life cycle management Orion Pharma 29th Annual Symposium of the

More information

STATE COORDINATION PROGRAM. for the Development of Biotechnology in the Russian Federation until Moscow, 2012 VP-P8 322

STATE COORDINATION PROGRAM. for the Development of Biotechnology in the Russian Federation until Moscow, 2012 VP-P8 322 APPROVED Prime Minister of the Russian Federation V.Putin April 24, 2012 No 1853p-P8 STATE COORDINATION PROGRAM for the Development of Biotechnology in the Russian Federation until 2020 Moscow, 2012 VP-P8

More information

Conducting Education, Training and Research in a Globalized Environment

Conducting Education, Training and Research in a Globalized Environment IAEA International Conference on Challenges Faced by Technical and Scientific Support Organizations (TSO) in Enhancing Nuclear Safety and Security 25-29 October 2010 Tokyo, Japan Conducting Education,

More information

About Company. OZNA is a large Russian multi profile company.

About Company. OZNA is a large Russian multi profile company. OZNA Company OZNA is a large Russian multi profile company. About Company It specializes in manufacturing of equipment and rendering of services for oil-gas field construction. The company carries out

More information

TOMSK REGION: From Resources to Smart Technology

TOMSK REGION: From Resources to Smart Technology TOMSK REGION: From Resources to Smart Technology ABOUT THE REGION Tomsk 1,078,891 people AVERAGE TEMPERATURE January -16 0 С July +24 0 С 314,400 km2 594,000 people One in ten is a student 72% urban population

More information

Russian Federation. Chapter 12. By Julianna Tabastajewa and Svetlana Rudevich

Russian Federation. Chapter 12. By Julianna Tabastajewa and Svetlana Rudevich Chapter 12 Russian Federation By Julianna Tabastajewa and Svetlana Rudevich Legal System The Russian Federation is a federal state consisting of a total of 83 republics, regions, federal cities, autonomous

More information

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG SCHEDULE Form 1 REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG THE REGISTRAR PHARAMCY BOARD MINISTRY OF HEALTH AND QUALITY OF LIFE MAURITIUS Fax: Telephone: TYPE OF APPLICATION HUMAN, BIOLOGICAL

More information

Geographical Position

Geographical Position Geographical Position Total area- 18 300 sq. m. Capital- Cheboksary Population over 1 243,4 thousand people 21 municipal districts, 5 urban districts, 7 urban и 284 rural settlements Population density

More information

Phylogica. Harnessing Biodiversity for Peptide Therapies. Life Sciences Showcase, 23 August 2011 Nick Woolf: CFO & VP Corporate Development

Phylogica. Harnessing Biodiversity for Peptide Therapies. Life Sciences Showcase, 23 August 2011 Nick Woolf: CFO & VP Corporate Development Phylogica Harnessing Biodiversity for Peptide Therapies Life Sciences Showcase, 23 August 2011 Nick Woolf: CFO & VP Corporate Development Introduction Biotech company offering leading peptide drug discovery

More information

Landscape of the European Chemical Industry 2018

Landscape of the European Chemical Industry 2018 Ireland BioPharmaChem Ireland National contact Capital spending Direct employees 10 billion > 30,000 R&D investment 600 million Matt Moran Director General matt.moran@ibec.ie CHEMICAL INDUSTRY SNAPSHOT

More information

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS

More information

Drug Research Center CIM Sant Pau

Drug Research Center CIM Sant Pau Drug Research Center CIM Sant Pau CIM Sant Pau began its activities in 1983, in partnership with the clinical pharmacology department of the Hospital de la Santa Creu i Sant Pau and the pharmacology and

More information

2.3. Intellectual Capital

2.3. Intellectual Capital ASE. Annual report 2016 2.3. Intellectual Capital Sergei Egorov, Director for Science and Innovation What is the main result of innovative activities in the reporting year? In 2016 the business unit of

More information

GMP considerations when designing an API plant. Presented by Cameron Roberts, Senior Engineer 4 July, 2016

GMP considerations when designing an API plant. Presented by Cameron Roberts, Senior Engineer 4 July, 2016 GMP considerations when designing an API plant Presented by Cameron Roberts, Senior Engineer 4 July, 2016 Introduction API manufacturing is too broad a topic to cover all scenarios so I will draw from

More information

Presse-Information Press release Information de presse

Presse-Information Press release Information de presse Presse-Information Press release Information de presse Kontakt/Contact: Dr. Kathrin Rübberdt Tel. ++49 (0) 69 / 75 64-2 77 Fax ++49 (0) 69 / 75 64-2 72 e-mail: presse@dechema.de Trend Report February 2018

More information

Distribution on the pharmaceutical market in Central Europe Development forecasts for

Distribution on the pharmaceutical market in Central Europe Development forecasts for Distribution on the pharmaceutical market in Central Europe 2014 2 Language: English Date of publication: Q4 Delivery: pdf Price from: 2500 Find out Which countries plan to limit the number of pharmacies

More information

Romania: Towards an RDI strategy with a strong smart specialization component

Romania: Towards an RDI strategy with a strong smart specialization component Romania: Towards an RDI strategy with a strong smart specialization component Bazat pe prezentarea la conferinta de S3 Peer Learning, Dublin, 2014 Despre UEFISCDI- One Stop Shop! National Strategy for

More information

ITC-ELECTRONICS. Integration of solutions for Engineering and Automation!

ITC-ELECTRONICS. Integration of solutions for Engineering and Automation! ITC-ELECTRONICS Integration of solutions for Engineering and Automation! ITC-Electronics is a global supplier of innovative technical solutions in the field of Engineering and Automation to the largest

More information

HSE Procurement. Hotel and Utilities Portfolio Presentation to CMAI Food and Bev Live Wednesday 1 st February 2012

HSE Procurement. Hotel and Utilities Portfolio Presentation to CMAI Food and Bev Live Wednesday 1 st February 2012 HSE Procurement Hotel and Utilities Portfolio Presentation to CMAI Food and Bev Live Wednesday 1 st February 2012 Strategic View Portfolio & Category Management 4.5bn Contractible Expenditure 4 Major Portfolios

More information

Index Day reports (ADR)...59, 125

Index Day reports (ADR)...59, 125 Index 15-Day reports (ADR)...59, 125 30-Day reports (ADR)...126 7-Day reports (ADR)...59 ADR reporting system Reporting by pharmaceutical companies...125 ADR Reporting System Reporting by MHLW...124 Advanced

More information

Certification of qualified persons for pharmaceutical production conditions and requirements of the Eurasian Economic Union

Certification of qualified persons for pharmaceutical production conditions and requirements of the Eurasian Economic Union Certification of qualified persons for pharmaceutical production conditions and requirements of the Eurasian Economic Union Natalya Pyatigorskaya Head of the Department of Industrial Pharmacy of the Sechenov

More information

Distribution on the pharmaceutical market in Romania Development forecasts for

Distribution on the pharmaceutical market in Romania Development forecasts for Distribution on the pharmaceutical market in Romania 2014 2 Language: English Date of publication: Q4 Delivery: pdf Price from: 950 Find out Which locations in Romania host the largest concentrations of

More information

Energy Efficiency Policy in Uzbekistan

Energy Efficiency Policy in Uzbekistan Energy Efficiency Policy in Uzbekistan Sirojiddin Akhmedov the chief specialist of the Department of EE and RES development, the Ministry of economy of the Republic of Uzbekistan Manila, Philippines June

More information

Comprehensive Collaboration Agreement between Osaka University and Chugai ~Total of 10 billion yen contribution over 10 years to IFReC~

Comprehensive Collaboration Agreement between Osaka University and Chugai ~Total of 10 billion yen contribution over 10 years to IFReC~ May 19, 2016 National University Corporation Osaka University Comprehensive Collaboration Agreement between Osaka University and Chugai ~Total of 10 billion yen contribution over 10 years to IFReC~ Outline

More information

Future Prospects and Barriers of Pharmaceutical Industries in Bangladesh

Future Prospects and Barriers of Pharmaceutical Industries in Bangladesh Bangladesh Pharmaceutical Journal 19(1): 53-57, 2016 Future Prospects and Barriers of Pharmaceutical Industries in Bangladesh Jesmin Sultana Department of Business Administration, University of Asia Pacific,

More information

RUSSIAN SPECIAL ECONOMIC ZONES

RUSSIAN SPECIAL ECONOMIC ZONES RUSSIAN SPECIAL ECONOMIC ZONES a JSC Special Economic Zones St. Petersburg 31 March 2011 SEZ is a large-scale federal project A Special Economic Zone is a part of the Russian Federation territory determined

More information

Third Pillar: Knowledge, Innovation and Scientific Research

Third Pillar: Knowledge, Innovation and Scientific Research 3 rd Pillar: Knowledge, Innovation & Scientific Third Pillar: Knowledge, Innovation and Scientific Overview of Current Situation The concept of knowledge,, and scientific research expands to include the

More information

Hannover, your first foothold for business expansion into Europe

Hannover, your first foothold for business expansion into Europe Hannover, your first foothold for business expansion into Europe Hannover Clinical Trial Center & hannoverimpuls Support for entering the health care market 1 The Hannover Region features all important

More information

Research and Innovation, Sweden - Japan

Research and Innovation, Sweden - Japan Research and Innovation, Sweden - Japan some reflections michael.jacob@gov.se Office of Science and Innovation Embassy of Sweden in Tokyo Ministry of Enterprise and Innovation Investment in R&D Innovation

More information

PHARMACEUTICAL INDUSTRIES IN TOYAMA

PHARMACEUTICAL INDUSTRIES IN TOYAMA PHARMACEUTICAL INDUSTRIES IN TOYAMA Profile(outline of Toyama Prefecture) Toyama prefecture is located near the center of Japan and is approximately the same distance from the three largest cities in Japan-Tokyo,Nagoya,and

More information

HNP Brief #3. Pharmaceuticals: Local Manufacturing. March Introduction. Overview of pharmaceutical companies in lowand middle-income countries

HNP Brief #3. Pharmaceuticals: Local Manufacturing. March Introduction. Overview of pharmaceutical companies in lowand middle-income countries HNP Brief #3 Pharmaceuticals: Local Manufacturing March 2005 Introduction Pharmaceuticals are essential in every health care system. The objective of pharmaceutical policy is to make sure that there is

More information

Volgograd State Agrarian University

Volgograd State Agrarian University Volgograd State Agrarian University Volgograd State Agrarian University is one of the greatest agricultural institutions of our country. It was founded in 1944 and is now headed by A.S. Ovchinnikov, Doctor

More information

CENTRAL EASTERN EUROPEAN PHARMACEUTICAL MANUFACTURING EXCELLENCE AWARD

CENTRAL EASTERN EUROPEAN PHARMACEUTICAL MANUFACTURING EXCELLENCE AWARD Application closes: 31 st of January 2018 CELEBRATING ACHIEVEMENTS CALL FOR APPLICATIONS for the 4th CEE Manufacturing Excellence Award THE CONGRESS THE CALL WHO CAN APPLY PHARM Connect Congress is the

More information

VYATKA INDUSTRIAL PARK

VYATKA INDUSTRIAL PARK VYATKA INDUSTRIAL PARK The Vyatka Industrial Park is a multi-purpose industrial park for production facilities of various industry branches. Priority Industry Branches biotechnologies for agriculture;

More information

Indian Pharmaceutical Industry. January 2018

Indian Pharmaceutical Industry. January 2018 Indian Pharmaceutical Industry January 2018 Introduction The pharmaceutical Industry around the world is one of the fastest growing industries and a major contributor to the world economy. 2020 55 1400

More information

Enterprise Systems in Healthcare - Blessing or Curse?

Enterprise Systems in Healthcare - Blessing or Curse? Enterprise Systems in Healthcare - Blessing or Curse? Research topics that interest me... Three agendas: n Evolution and assessment of information systems Evolution of information systems Business value

More information

Organization SUSTAINABILITY MANAGEMENT. Environmental Management Sub-area CSR. Management Sub-area. Energy and Waste. Board of Directors

Organization SUSTAINABILITY MANAGEMENT. Environmental Management Sub-area CSR. Management Sub-area. Energy and Waste. Board of Directors Organization IdM operates under the responsibility of a Director, a Board of Directors with operational tasks, and a Board that is responsible for strategic planning. A Scientific Board monitors and supports

More information

Opportunities for Collaboration

Opportunities for Collaboration The 40th Joint Conference between ROC-Korea and Korea-Taiwan Business Councils Opportunities for Collaboration in Bio & Pharmaceutical Industry Leah Lo, Ph.D./ President Medical and Pharmaceutical Industry

More information

Plasma and Beam Equipment for Materials Processing (Education and Science)

Plasma and Beam Equipment for Materials Processing (Education and Science) Tomsk Polytechnic University (TPU) Physics and Technology Institute (PTI) Plasma and Beam Equipment for Materials Processing (Education and Science) Prof. Valery Krivobokov Russia, Siberia and Tomsk Moscow

More information

Santara Valley experience in new health technologies. Vladas Algirdas Bumelis

Santara Valley experience in new health technologies. Vladas Algirdas Bumelis Santara Valley experience in new health technologies Vladas Algirdas Bumelis 1 Santara Valley Integrated scientific and business center was established in 2008. It will be finished by the end of 2013.

More information

Policy principles for a competitive healthcare environment

Policy principles for a competitive healthcare environment Policy principles for a competitive healthcare environment Pharmaceutical Research and Development Industry Malta Association (PRIMA) PRIMA is an affiliate of the European Federation of Pharmaceutical

More information

Bio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies

Bio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies Global Strategy Global Challenges Executable Solutions Bio-Pharma: China 2010-2020 A Look at The FUTURE: 4 th & 5 th Generation Global Strategies France Houdard Managing Director January 2010 Table of

More information

Pharmaceutical market 2015: CRISIS

Pharmaceutical market 2015: CRISIS Pharmaceutical market 2015: CRISIS Sergey Shulyak CEO DSM Group St. Petersburg 17 May, 2016 Over the past 5 years, the average growth of the Russian pharmaceutical market makes 11% in rubles Market dynamics

More information

CLINICAL TRIALS IN RUSSIA

CLINICAL TRIALS IN RUSSIA RESEARCH REPORT CLINICAL TRIALS IN RUSSIA SUMMER 2018 RESEARCH GROUP WWW.SRGCRO.COM FOREWORD The Orange Paper is a free publication produced by Synergy Research Group for the pharmaceutical industry since

More information

Program of study. pharmacy. 1st year

Program of study. pharmacy. 1st year II I Program of study pharmacy 1st year Anatomy 15-15 GC Biophysics 15 15 - E Biology and Genetics 60 15 15 E 4 Botany 90 45 15 E 7 Analytical I 4 1 - E General and Inorganic 105 45 E 7 Latin Course -

More information

The VIII St. Petersburg International Legal Forum May 15-19, Business Programme

The VIII St. Petersburg International Legal Forum May 15-19, Business Programme The VIII St. Petersburg International Legal Forum May 15-19, 2018 Business Programme Plenary Session Plenary Session Future of the Legal Profession Award Ceremony for the Laureate of the St. Petersburg

More information

TEDA. Where Investor is The King. TEDA Administrative Commission

TEDA. Where Investor is The King. TEDA Administrative Commission TEDA Where Investor is The King TEDA Administrative Commission 05.2012 April, 2012 Content TEDA Overview Successful Stories Client-oriented Services Important Facts Tianjin Economic-technological Development

More information

to acquire Investor And Analyst Call Presentation January 4, 2008

to acquire Investor And Analyst Call Presentation January 4, 2008 to acquire Investor And Analyst Call Presentation January 4, 2008 Safe Harbor Statement The following information contains, or may be deemed to contain, forward looking statements (as defined in the U.S.

More information

Foreign Affairs, Defence and Trade Select Committee Parliament Wellington. 24 March 2016

Foreign Affairs, Defence and Trade Select Committee Parliament Wellington. 24 March 2016 Foreign Affairs, Defence and Trade Select Committee Parliament Wellington 24 March 2016 Dear Committee Members, Our apologies for a delayed written submission (attached) on the International treaty examination

More information

Jefferies 2015 Global Healthcare Conference June 3, 2015

Jefferies 2015 Global Healthcare Conference June 3, 2015 Jefferies 2015 Global Healthcare Conference June 3, 2015 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Import and Export of Skills and Talents

Import and Export of Skills and Talents Import and Export of Skills and Talents Professor Eleftherios Iakovou Director, Division Of Industrial Management Director, Laboratory for Supply Chain Management and Logistics Aristotle University of

More information

FIP STATEMENT OF POLICY Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution

FIP STATEMENT OF POLICY Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution Purpose: The purpose of this document is to provide a set of recommendations on therapeutic interchange

More information

PACKAGE SUPPLIES OF POWER EQUIPMENT

PACKAGE SUPPLIES OF POWER EQUIPMENT NEW GENERATION TECHNOLOGIES PACKAGE SUPPLIES OF POWER EQUIPMENT 01 COMPANY STRUCTURE REP Holding is a leading power machine building company in Russia Founded in 2004 Incorporated in JSC Gazprombank industrial

More information

Russian Pharmaceutical Market Trends in 2017 Track & trace system: additional costs or opportunities? Deloitte CIS Research Centre Moscow, 2017

Russian Pharmaceutical Market Trends in 2017 Track & trace system: additional costs or opportunities? Deloitte CIS Research Centre Moscow, 2017 Russian Pharmaceutical Market Trends in 27 Track & trace system: additional costs or opportunities? Deloitte CIS Research Centre Moscow, 27 Russian Pharmaceutical Market Trends in 27 Contents Russian in

More information

[ Feature ] Biotechnology Parks: China into the Next Future

[ Feature ] Biotechnology Parks: China into the Next Future Photo credit: China Beijing Bioengineering and Pharmaceutical Industrial Park (CBP) More than just an incubator base for research and discovery, China Beijing Bioengineering and Pharmaceutical Industrial

More information

Russian Medical Device Market 2013

Russian Medical Device Market 2013 Russian Medical Device Market 2013 Summary The global medical device market has been growing steadily over the last years, expanding by 5% between 2009 and 2013. The Russian medical market grew by 12%

More information

State Control of Medicines and Medical Devices in Russian Federation

State Control of Medicines and Medical Devices in Russian Federation Federal Service for Surveillance in Healthcare State Control of Medicines and Medical Devices in Russian Federation Ph.D., Elena Astapenko The Head of the Department of organization of state control and

More information

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority CHALLENGES AND OPPORTUNITIES IN COLD CHAIN: HEALTH CARE RELATED DRIVERS Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority AGENDA Integrating stakeholders

More information

Technology Transfer, Academic and Industry Cooperations

Technology Transfer, Academic and Industry Cooperations Technology Transfer, Academic and Industry Cooperations Jake Micallef PhD MBA COO ValiRx plc Visiting lecturer Simfonec Jake.micallef@valirx.com What do they want? Universities Money to fund research and

More information

Tackling North America s Workforce Challenges

Tackling North America s Workforce Challenges Tackling North America s Workforce Challenges E. Anthony Wayne Career Ambassador (ret.) Public Policy Fellow at the Wilson Center wayneea@gmail.com @EAnthonyWayne Presentation to NASCO 2017 Workforce Forum

More information

Pharmacophore 2011, Vol. 2 (6), ISSN Pharmacophore. (An International Research Journal)

Pharmacophore 2011, Vol. 2 (6), ISSN Pharmacophore. (An International Research Journal) Pharmacophore 2011, Vol. 2 (6), 271-275 ISSN 2229 5402 Pharmacophore (An International Research Journal) Available online at http://www.pharmacophorejournal.com/ Review Article A REVIEW: EXPLORING BRANDED

More information

Jefferies 2018 Global Healthcare Conference. June 7, 2018

Jefferies 2018 Global Healthcare Conference. June 7, 2018 Jefferies 2018 Global Healthcare Conference June 7, 2018 Forward-Looking Statements Statements in this presentation regarding the future financial and operating results, outlook, growth, prospects, business

More information

Derm Drugs: The Price is Too Darn High!

Derm Drugs: The Price is Too Darn High! Derm Drugs: The Price is Too Darn High! By Jacob Levitt, MD, FAAD Vice Chairman, Program Director, and Associate Professor The Mount Sinai Medical Center Department of Dermatology New York, NY 1 Disclosures

More information

MULTIDISCIPLINARY ACTIVITY IN THE HEALTHCARE MARKET

MULTIDISCIPLINARY ACTIVITY IN THE HEALTHCARE MARKET MULTIDISCIPLINARY ACTIVITY IN THE HEALTHCARE MARKET LOCATION Bydgoszcz We have two offices: in Bydgoszcz (head office) on the North and Katowice on the South of Poland. Since 2015 Bioscience has been a

More information

CERTIFICATE IN BIOPHARMACEUTICALS

CERTIFICATE IN BIOPHARMACEUTICALS Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034-2713 Phone: 267.468.8560 Fax: 267.468.8565 CERTIFICATE IN BIOPHARMACEUTICALS and GENERIC DRUGS Temple offers

More information

Ukraine Action Plan. Translation

Ukraine Action Plan. Translation Ukraine Action Plan Translation The German Government is supporting Ukraine s political and economic stabilisation via an action plan involving ministries, implementing and partner organisations, the business

More information

Contact Information: Rapture Biotech D-201, Sector - 10, Noida Uttar Pradesh. Phone , ,

Contact Information: Rapture Biotech D-201, Sector - 10, Noida Uttar Pradesh. Phone , , Topics Covered: MODULE 1 Introduction To Pharmacovigilance Terminologies used in Pharmacovigilance ADRs Polypharmacy MODULE 2 Pharmacoepidemiology Iatrogenesis Prescription-event monitoring MODULE 3 SAE

More information

An application for a license to market a generic (or a duplicate) version of a drug that has already been granted an approval under a full NDA.

An application for a license to market a generic (or a duplicate) version of a drug that has already been granted an approval under a full NDA. ANDA REQUIREMENTS 1 Abbreviated New Drug Application (ANDA) An application for a license to market a generic (or a duplicate) version of a drug that has already been granted an approval under a full NDA.

More information

Gas Turbine Opportunities in Russia

Gas Turbine Opportunities in Russia Joint Stock Company REP Holding Gas Turbine Opportunities in Russia Franco Rosatelli Vice-President for Technological Development JSC REP Holding Russian Federation 1 Energy scenario in Russia Russia domestic

More information

Section I: Pharmaceuticals and Medical Devices

Section I: Pharmaceuticals and Medical Devices SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical

More information

Pharmacovigilance System in Russia and the EAEU

Pharmacovigilance System in Russia and the EAEU Pharmacovigilance System in Russia and the EAEU Authors: Sergey Simeniv CEO X7 Research, CRO; Olga Latysheva Head of Pharmacovigilance Department X7 Research, CRO; Dmitry Kryuchkov Executive Director X7

More information

ROSATOM HR SOLUTION APPROACH TO HUMAN RESOURCE DEVELOPMENT

ROSATOM HR SOLUTION APPROACH TO HUMAN RESOURCE DEVELOPMENT ROSATOM HR SOLUTION APPROACH TO HUMAN RESOURCE DEVELOPMENT ROSATOM HR PRIORITIES ROSATOM HR priorities are closely related to its Strategic Goals: An increase of our share on international markets Development

More information

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications. APPENDIX 2 SURVEY QUESTIONNAIRE Part I. Basic Information I.1 If your company performs biotechnology research and development, uses a biotechnology process in manufacturing, or produces research tools,

More information

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017 Investor Presentation 2017 RBC Capital Markets Global Healthcare Conference February 22, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private

More information

The Journey to Shared Value

The Journey to Shared Value The Journey to Shared Value INSTITUTE OF MEDICINE FORUM ON PUBLIC-PRIVATE PARTNERSHIPS FOR GLOBAL HEALTH AND SAFETY DECEMBER 3, 2015 FSG 1 What does the shared value journey look like for these companies?

More information

The Future of Consumer Health Care

The Future of Consumer Health Care The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

More information

L A B O R M A R K E T B R I E F I N G S S E R I E S

L A B O R M A R K E T B R I E F I N G S S E R I E S L A B O R M A R K E T B R I E F I N G S S E R I E S LABOR MARKET INFORMATION FOR RESEARCHERS THE LIFE SCIENCE AND PHARMACEUTICALS SECTOR IN EUROPE L I F E S C I E N C E A N D P H A R M A C E U T I C A

More information

UNIVERSITY OF MUMBAI

UNIVERSITY OF MUMBAI Academic Council 25/05/2011 Item No. 4.71 UNIVERSITY OF MUMBAI Syllabus for Clinical Studies Program: Diploma Course: Post Graduate Diploma in Clinical Studies, Data Management & Medical Writing (Introduced

More information